EP0523141A4 - Substituted pyrazoles, isoxazoles and isothiazoles - Google Patents

Substituted pyrazoles, isoxazoles and isothiazoles

Info

Publication number
EP0523141A4
EP0523141A4 EP19910907490 EP91907490A EP0523141A4 EP 0523141 A4 EP0523141 A4 EP 0523141A4 EP 19910907490 EP19910907490 EP 19910907490 EP 91907490 A EP91907490 A EP 91907490A EP 0523141 A4 EP0523141 A4 EP 0523141A4
Authority
EP
European Patent Office
Prior art keywords
isothiazoles
isoxazoles
substituted pyrazoles
pyrazoles
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19910907490
Other versions
EP0523141A1 (en
Inventor
Eric E. Allen
William J. Greenlee
Malcolm Maccoss
Wallace T. Ashton
Stephen L. De Laszlo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of EP0523141A1 publication Critical patent/EP0523141A1/en
Publication of EP0523141A4 publication Critical patent/EP0523141A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
EP19910907490 1990-03-30 1991-03-27 Substituted pyrazoles, isoxazoles and isothiazoles Withdrawn EP0523141A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50146990A 1990-03-30 1990-03-30
US501469 1990-03-30

Publications (2)

Publication Number Publication Date
EP0523141A1 EP0523141A1 (en) 1993-01-20
EP0523141A4 true EP0523141A4 (en) 1993-04-21

Family

ID=23993680

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19910907490 Withdrawn EP0523141A4 (en) 1990-03-30 1991-03-27 Substituted pyrazoles, isoxazoles and isothiazoles

Country Status (4)

Country Link
EP (1) EP0523141A4 (en)
JP (1) JPH05505822A (en)
CA (1) CA2079343A1 (en)
WO (1) WO1991015479A1 (en)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5591761A (en) * 1993-05-20 1997-01-07 Texas Biotechnology Corporation Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US5962490A (en) 1987-09-25 1999-10-05 Texas Biotechnology Corporation Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
GB9110623D0 (en) * 1991-05-16 1991-07-03 Glaxo Group Ltd Chemical compounds
AP254A (en) * 1991-09-05 1993-05-05 Glaxo Group Ltd C-Linked pyrazole derivatives.
WO1993005025A1 (en) * 1991-09-06 1993-03-18 Glaxo Group Limited C-linked pyrazole derivatives
GB2263638A (en) * 1992-01-28 1993-08-04 Merck & Co Inc Substituted pyrazoles, isoxazoles and isothiazoles as neurotensin antagonists
FR2687675B1 (en) * 1992-01-31 1997-04-18 Roussel Uclaf NOVEL BICYCLIC PYRIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION, THE NEW INTERMEDIATES OBTAINED, THEIR APPLICATION AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
US5326776A (en) * 1992-03-02 1994-07-05 Abbott Laboratories Angiotensin II receptor antagonists
US5514696A (en) * 1992-05-06 1996-05-07 Bristol-Myers Squibb Co. Phenyl sulfonamide endothelin antagonists
JPH06239859A (en) * 1992-09-14 1994-08-30 Takeda Chem Ind Ltd Cyclic compound having angiotensin i antagonism and its use
ATE204276T1 (en) * 1992-12-22 2001-09-15 Takeda Chemical Industries Ltd HETEROCYCLIC COMPOUNDS HAVING ANGIOTENSIN II ANTAGONISTIC ACTION AND THEIR APPLICATION
JP3412887B2 (en) * 1992-12-22 2003-06-03 武田薬品工業株式会社 Heterocyclic compounds having angiotensin II antagonistic activity and uses thereof
US5262412A (en) * 1993-03-10 1993-11-16 Merck & Co., Inc. Substituted pyrazoles, compositions and use
US6376523B1 (en) 1994-05-20 2002-04-23 Texas Biotechnology Corporation Benzenesulfonamides and the use thereof to modulate the activity of endothelin
US6541498B2 (en) 1993-05-20 2003-04-01 Texas Biotechnology Benzenesulfonamides and the use thereof to modulate the activity of endothelin
US5612359A (en) * 1994-08-26 1997-03-18 Bristol-Myers Squibb Company Substituted biphenyl isoxazole sulfonamides
US5780473A (en) * 1995-02-06 1998-07-14 Bristol-Myers Squibb Company Substituted biphenyl sulfonamide endothelin antagonists
US5760038A (en) * 1995-02-06 1998-06-02 Bristol-Myers Squibb Company Substituted biphenyl sulfonamide endothelin antagonists
US5846990A (en) * 1995-07-24 1998-12-08 Bristol-Myers Squibb Co. Substituted biphenyl isoxazole sulfonamides
JPH09124620A (en) 1995-10-11 1997-05-13 Bristol Myers Squibb Co Substituted biphenylsulfonamide endothelin antagonist
US5856507A (en) * 1997-01-21 1999-01-05 Bristol-Myers Squibb Co. Methods for the preparation of biphenyl isoxazole sulfonamides
HUP0002351A3 (en) 1996-02-20 2001-10-29 Bristol Myers Squibb Co Methods for the preparation of biphenyl isoxazole sulfonamides, intermediates and process for preparing them
US5939446A (en) * 1996-04-09 1999-08-17 Bristol-Myers Squibb Co. Heteroaryl substituted phenyl isoxazole sulfonamide endothelin antagonists
US6297198B1 (en) 1996-05-14 2001-10-02 Syngenta Participations Ag Isoxazole derivatives and their use as herbicides
TW536540B (en) * 1997-01-30 2003-06-11 Bristol Myers Squibb Co Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe
AU6187898A (en) * 1997-01-30 1998-08-25 Bristol-Myers Squibb Company Method for preventing or treating low renin hypertension by administering an endothelin antagonist
US6638937B2 (en) 1998-07-06 2003-10-28 Bristol-Myers Squibb Co. Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
DE69940958D1 (en) 1998-12-23 2009-07-16 Glaxo Group Ltd DETERMINATION METHOD FOR LIGANDS OF NUCLEAR RECEPTORS
WO2000056685A1 (en) 1999-03-19 2000-09-28 Bristol-Myers Squibb Company Methods for the preparation of biphenyl isoxazole sulfonamides
SE9903028D0 (en) 1999-08-27 1999-08-27 Astra Ab New use
NZ519717A (en) 1999-12-31 2003-06-30 Texas Biotechnology Corp Sulfonamides and derivatives thereof that modulate the activity of endothelin
GB0225548D0 (en) 2002-11-01 2002-12-11 Glaxo Group Ltd Compounds
MX354786B (en) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS, INFLAMMATION, CANCER and OTHER DISORDERS.
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
ES2627848T3 (en) 2008-06-04 2017-07-31 Synergy Pharmaceuticals Inc. Guanylate cyclase agonists useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
ES2624828T3 (en) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Guanylate cyclase agonists useful for the treatment of gastrointestinal disorders, inflammation, cancer and others
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
US9486494B2 (en) 2013-03-15 2016-11-08 Synergy Pharmaceuticals, Inc. Compositions useful for the treatment of gastrointestinal disorders
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
KR102272746B1 (en) 2013-06-05 2021-07-08 보슈 헬스 아일랜드 리미티드 Ultra-pure agonists of guanylate cyclase c, method of making and using same
AU2019387370A1 (en) 2018-11-30 2021-06-10 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0446062A1 (en) * 1990-03-09 1991-09-11 Glaxo Group Limited C-Linked pyrazole derivatives
EP0449699A2 (en) * 1990-03-19 1991-10-02 Laboratoires Upsa Pyrazole derivatives as angiotensin II-receptor antagonists, process for their preparation and pharmaceutical compositions containing them

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2823011A1 (en) * 1978-05-26 1979-11-29 Wacker Chemie Gmbh TO ELASTOMER CROSSLINKABLE DIMENSIONS

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0446062A1 (en) * 1990-03-09 1991-09-11 Glaxo Group Limited C-Linked pyrazole derivatives
EP0449699A2 (en) * 1990-03-19 1991-10-02 Laboratoires Upsa Pyrazole derivatives as angiotensin II-receptor antagonists, process for their preparation and pharmaceutical compositions containing them

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9115479A1 *

Also Published As

Publication number Publication date
WO1991015479A1 (en) 1991-10-17
EP0523141A1 (en) 1993-01-20
CA2079343A1 (en) 1991-10-01
JPH05505822A (en) 1993-08-26

Similar Documents

Publication Publication Date Title
EP0523141A4 (en) Substituted pyrazoles, isoxazoles and isothiazoles
ZA927377B (en) Dispersions.
EP0604504A4 (en) Iontotherapeutic device and process.
HU9200880D0 (en) Storing process for agrochemicalst and the like
IL116507A0 (en) Pyrazole derivatives
IL97821A0 (en) 3,5-disubstituted 2-isoxazolines and isoxazoles,processes for their preparation,agents containing them and their use
NZ238552A (en) Benzodiazepin-2-amine derivatives; preparatory processes, use, and medicaments
HU9204030D0 (en) Fungicidal preparatives containing 2-imidazoline-5-ones and 5-thiones thereof
ZA927079B (en) Process and kit for dyeing hair.
ZA923767B (en) Azole derivatives
EP0495750A3 (en) Heterocyclic hydroxylamine
ZA927172B (en) Heterocyclic compounds and their preparation and use.
GB9127359D0 (en) R.f.mixer
EP0515041A3 (en) Fungicidal pyrazoles, pyrazolines and tetrahydropyridazines
ZA927792B (en) Anti-alpha6-integrin-antibodies.
ZA929375B (en) N-aryl-nitrogen heterocycles.
IL98309A0 (en) Plant-protecting substituted isoxazolines,isoxazoles,isothiozolines and isothiazoles,processes for their preparation and their use
ZA927998B (en) Pyrazolines.
ZA929762B (en) Novel thiazoles.
ZA933815B (en) Pyrimidinyl- and triazinyl-salicyl- and -picolyl- amides and the use and preparation thereof.
ZA921865B (en) Isoxazole- and isothiazole-5-carboxamides.
IE900919L (en) Indazoles, benzisoxazoles and benzisothiazoles
ZA929718B (en) Microbicides.
ZA928765B (en) Novel 3-halo-5-halomethyl-2-oxazolidinones and their use as microbicides.
ZA929823B (en) Microbicides.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19920923

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): CH DE FR GB IT LI NL

A4 Supplementary search report drawn up and despatched

Effective date: 19930303

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): CH DE FR GB IT LI NL

17Q First examination report despatched

Effective date: 19950210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19950822